TMO

2025Q1BMO

Thermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2025-04-23 · Fiscal end 2025-03-31 · Features as of 2025-04-22

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS5.10
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.5%
IV front—
P/C full—
P/C front—
Features as of2025-04-22

Run-up

Close—
Ret 5d-3.2%
Ret 10d-0.7%
Ret 20d-16.4%
Ret 30d-17.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
5.15Beat
Estimated EPS5.10
Actual revenue
10.4B
Surprise %+1.0%
Beat / missBeat
Beat streak 44
Beat streak 87

Reaction

1-day stock reaction-5.5%
Implied vs actual

Implied 2.5%Actual 5.0%

Gap reaction+5.0%
Day result-0.7%
Next-day upNo
Realized / IV2.03×

Post tape

Post 5d-0.6%
Post 10d-5.5%
Post volume3.5M
Vol ×10d1.13×
Vol ×20d1.30×
Post range7.1%